Patents by Inventor John Daniel

John Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260115357
    Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.
    Type: Application
    Filed: January 15, 2025
    Publication date: April 30, 2026
    Applicant: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Richard Berg
  • Patent number: 12447232
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: July 12, 2023
    Date of Patent: October 21, 2025
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Patent number: 12290613
    Abstract: Described herein are compositions composed of micronized particles derived from one or more components present in placental tissue in combination with one or more bone grafts. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: May 6, 2025
    Assignee: MiMedx Group, Inc.
    Inventors: John Daniel, Randall Spencer, Robert Tofe
  • Publication number: 20250099648
    Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.
    Type: Application
    Filed: November 27, 2024
    Publication date: March 27, 2025
    Applicant: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Richard Berg
  • Publication number: 20240366838
    Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.
    Type: Application
    Filed: July 10, 2024
    Publication date: November 7, 2024
    Applicant: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Richard Berg
  • Patent number: 12083244
    Abstract: Described herein are tissue grafts produced by contacting dehydrated placental tissue grafts with a cross-linking agent. The tissue grafts described herein provide barrier and prevent the migration of a bioactive agent from the wound. Thus, the tissue grafts enhance wound healing while preventing the undesirable migration of a bioactive agent from the wound. Methods for making and using the cross-linked grafts are also described herein.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: September 10, 2024
    Assignee: MiMedx Group, Inc.
    Inventors: Tom Koob, John Daniel, Randall Spencer
  • Patent number: 12064530
    Abstract: Compositions comprising perforated, unseparated amnion/chorion; perforated, separated amnion; and perforated, separated chorion derived from the placenta and methods of preparing and using those compositions are provided. Perforation of placental tissue before or during processing may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the perforated compositions of the invention to the wound.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: August 20, 2024
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Richard Berg
  • Patent number: 11931384
    Abstract: Described herein are compositions composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: March 19, 2024
    Assignee: MiMedx Group, Inc.
    Inventors: Brenda S. Morse, Somaly Sith, Randall Spencer, Steven Ray, John Daniel, Robert Tofe
  • Publication number: 20240024536
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 25, 2024
    Applicant: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Publication number: 20230414670
    Abstract: Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.
    Type: Application
    Filed: September 11, 2023
    Publication date: December 28, 2023
    Applicant: MiMedx Group, Inc.
    Inventors: John Daniel, Randall Spencer, John Russo, Robert Tofe
  • Patent number: 11752174
    Abstract: Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: September 12, 2023
    Assignee: MiMedx Group, Inc.
    Inventors: John Daniel, Randall Spencer, John Russo, Robert Tofe
  • Patent number: 11744918
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: September 5, 2023
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Patent number: 11738115
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: August 29, 2023
    Assignee: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy
  • Publication number: 20230201419
    Abstract: A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic membrane, mounting a selected layer of either the chorion tissue or the amniotic membrane onto a drying fixture, dehydrating the selected layer on the drying fixture, and cutting the selected layer into a plurality of tissue grafts. Preferably, the drying fixture includes grooves or raised edges that define the outer contours of each desired tissue graft, after they are cut, and further includes raised or indented logos that emboss the middle area of the tissue grafts during dehydration and that enables an end user to distinguish the top from the bottom side of the graft. The grafts are comprised of single layers of amnion or chorion, multiple layers of amnion or chorion, or multiple layers of a combination of amnion and chorion.
    Type: Application
    Filed: November 4, 2022
    Publication date: June 29, 2023
    Applicant: MiMedx Group, Inc.
    Inventor: John Daniel
  • Publication number: 20230126319
    Abstract: Uncultured amniotic cell and protein fraction products derived from amniotic fluid and methods of preparing and using those compositions are provided. According to the methods of the present invention, uncultured amniotic cell and protein products may be derived from a large sample of amniotic fluid to provide a higher concentration of tissue regeneration components. Described are methods for separating uncultured amniotic cells or protein fractions from other components of amniotic fluid and the resulting uncultured amniotic cell and protein products. Furthermore, the present invention includes methods for delivering the uncultured amniotic cell and protein products to the skin and eye, including before, during, or after a treatment procedure.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 27, 2023
    Applicant: StimLabs LLC
    Inventors: John Daniel, Richard A. Berg, Sarah Griffiths
  • Publication number: 20230103744
    Abstract: Compositions comprising unseparated amnion/chorion derived from the placenta and methods of preparing and using those compositions are provided. Washing or preservation of placental tissue according to the methods of the disclosure may allow for one or more benefits such as more efficient removal of blood remnants, retention of wound healing and tissue regeneration components, better handling characteristics, increased absorption potential, or improved healing capacity. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, or dura comprising applying the compositions of the invention to the wound.
    Type: Application
    Filed: November 29, 2022
    Publication date: April 6, 2023
    Applicant: StimLabs LLC
    Inventors: John Daniel, Sarah Griffiths, Richard Berg
  • Patent number: 11607430
    Abstract: Described herein are dehydrated, laminated tissue grafts composed of two or more membrane layers of an amnion membrane, a chorion membrane, a Wharton's jelly, or an intermediate tissue layer, where a layer of micronized placental tissue is interposed between two of the layers. Also described herein are methods for making and using the laminated tissue grafts.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: March 21, 2023
    Assignee: MiMedx Group, Inc.
    Inventors: Thomas J. Koob, John Daniel, Randall Spencer
  • Patent number: 11602549
    Abstract: Described herein are tissue grafts derived from the placenta with improved physical and biological properties. In one aspect, the tissue graft includes a first membrane comprising Wharton's jelly laminated with amnion, chorion, or a combination thereof. The presence of Wharton's jelly in the grafts enhances the performance of allograft amniotic-derived, caderivic allograft, xenograft, or alloplast soft tissue substitutes.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: March 14, 2023
    Assignee: MiMedx Group, Inc.
    Inventors: Brenda S. Morse, Somaly Sith, Randall Spencer, John Daniel, Robert Tofe
  • Patent number: 11559553
    Abstract: Uncultured amniotic cell and protein fraction products derived from amniotic fluid and methods of preparing and using those compositions are provided. According to the methods of the present invention, uncultured amniotic cell and protein products may be derived from a large sample of amniotic fluid to provide a higher concentration of tissue regeneration components. Described are methods for separating uncultured amniotic cells or protein fractions from other components of amniotic fluid and the resulting uncultured amniotic cell and protein products. Furthermore, the present invention includes methods for delivering the uncultured amniotic cell and protein products to the skin and eye, including before, during, or after a treatment procedure.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: January 24, 2023
    Assignee: StimLabs LLC
    Inventors: John Daniel, Richard A. Berg, Sarah Griffiths
  • Patent number: 11504449
    Abstract: A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic membrane, mounting a selected layer of either the chorion tissue or the amniotic membrane onto a drying fixture, dehydrating the selected layer on the drying fixture, and cutting the selected layer into a plurality of tissue grafts. Preferably, the drying fixture includes grooves or raised edges that define the outer contours of each desired tissue graft, after they are cut, and further includes raised or indented logos that emboss the middle area of the tissue grafts during dehydration and that enables an end user to distinguish the top from the bottom side of the graft. The grafts are comprised of single layers of amnion or chorion, multiple layers of amnion or chorion, or multiple layers of a combination of amnion and chorion.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: November 22, 2022
    Assignee: MiMedx Group, Inc.
    Inventor: John Daniel